(Q47177355)

11 January 2018

title

Tumor size, axillary lymph node status and steroid receptor expression in breast cancer: prognostic relevance 5 years after surgery (English)

1 reference

11 January 2018

0 references

Gerhard Gebauer

1

1 reference

11 January 2018

Tanja Fehm

series ordinal

2

1 reference

11 January 2018

Norbert Lang

series ordinal

3

1 reference

11 January 2018

Wolfram Jäger

series ordinal

4

1 reference

11 January 2018

language of work or name

English

0 references

publication date

1 September 2002

1 reference

11 January 2018

Breast Cancer Research and Treatment

published in

1 reference

11 January 2018

volume

75

1 reference

11 January 2018

issue

2

1 reference

11 January 2018

page(s)

167-173

1 reference

11 January 2018

Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601928290

Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601928290

Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601928290

7 January 2021

Clinical utility of serial serum c-erbB-2 determinations in the follow-up of breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601928290

7 January 2021

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601928290

7 January 2021

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601928290

7 January 2021

Significance of axillary lymph node metastasis in primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601928290

7 January 2021

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601928290

7 January 2021

Prognostic factors and treatment decisions in axillary-node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601928290

7 January 2021

Prognostic and predictive factors in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601928290

7 January 2021

Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601928290

7 January 2021

Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601928290

7 January 2021

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601928290

7 January 2021

Molecular quantification and mapping of lymph-node micrometastases in cervical cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601928290

7 January 2021

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1019601928290

7 January 2021

Identifiers

DOI

10.1023/A:1019601928290

1 reference

11 January 2018

Dimensions Publication ID

1035412212

0 references

1 reference

11 January 2018